Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001841401-26-000005

General Counsel acquired 24,236 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wahl Bryan General Counsel 2026-03-15 Option exercise +24,236 76,399 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wahl Bryan General Counsel 2026-03-15 Option exercise · Restricted Stock Units −4,790 0 D: show line 2 in the form
Wahl Bryan General Counsel 2026-03-15 Option exercise · Restricted Stock Units −7,248 7,249 D: show line 3 in the form
Wahl Bryan General Counsel 2026-03-15 Option exercise · Restricted Stock Units −7,176 14,351 D: show line 4 in the form
Wahl Bryan General Counsel 2026-03-15 Option exercise · Restricted Stock Units −5,022 15,067 D: show line 5 in the form
Loading xslF345X05/wk-form4_1773779905.xml…